Colgate invests in gene therapy

11/7/2005 | NYTimes.com

Colgate-Palmolive and Introgen Therapeutics announced a partnership to pursue gene therapy mouthwashes and gels to treat and prevent oral cancers. Colgate-Palmolive is buying $20 million worth of Introgen's stock in a deal the companies hope will eventually develop prescription and over-the-counter products.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Food & Beverage

Job Title Company Location
Staff Assistant, Food Trucks/Commissary Manager
University of Massachusetts Amherst
Amherst, MA
Retail Food Services Manager
University of Massachusetts Amherst
Amherst, MA
Executive Pastry Chef
Princeton University
Princeton, NJ